2026年正子断层扫描（PET）放射性追踪剂全球市场报告

近年来，正子断层扫描（PET）放射性追踪剂市场成长显着，预计将以9.2%的复合年增长率成长，从2025年的25.4亿美元成长到2026年的27.8亿美元。过去几年的成长可归因于癌症诊断率的提高、核医设施的扩建、基于FDG的影像诊断的建立、迴旋加速器基础设施的发展以及诊断影像服务的扩展等因素。

预计未来几年正子断层扫描（PET）放射性追踪剂市场将强劲成长，2030年市场规模将达39.5亿美元，复合年增长率（CAGR）为9.2%。预测期内的成长要素包括：对精准诊断的需求不断增长、放射性药物治疗诊断学投入增加、诊疗一体化应用范围扩大、PET影像在神经病学和心臟病学领域的应用日益广泛，以及新型示踪剂获得监管部门核准的增多。预测期内的主要趋势包括：靶向特异性放射性示踪剂的研发不断推进、PET成像在肿瘤诊断领域的应用日益广泛、FDG以外的新型同位素的应用不断扩展、个性化核医学的应用日益增多，以及对短半衰期放射性示踪剂生产的日益重视。

预计未来几年，感染疾病的日益普及将推动正子断层扫描（PET）放射性追踪剂市场的成长。感染疾病是由致病微生物（例如细菌、病毒、真菌和寄生虫）引起的疾病。这些疾病的增加归因于气候变迁、都市化、全球化、抗生素抗药性和人类行为改变等因素，所有这些因素都促进了病原体的传播。 PET放射性追踪剂透过可视化代谢活动和炎症，有助于感染疾病的管理，从而促进感染的检测、治疗效果的评估以及感染疾病和非感染疾病的鑑别，进而改善患者的治疗效果。例如，根据英国英国机构卫生安全局（Health Security）于2024年2月发布的报告，英格兰的结核病（TB）病例数将在2023年增加10.7%，达到4850例（高于2022年的4,380例）。因此，感染疾病负担的加重促进了PET放射性示踪剂市场的扩张。

正子断层扫描 (PET) 放射性追踪剂市场的企业致力于开发先进的诊断解决方案，包括 PET 造影剂，旨在提高癌症检出率并改善患者预后。 PET 造影剂是一种放射性物质，可在 PET 扫描过程中对体内生物过程进行视觉化和定量分析。例如，2023 年 3 月，总部位于加拿大的放射性药物公司 IsoLogic Innovative Radiopharmaceuticals 在加拿大推出了 Illuccix（也称为 Ga-68 Gozetotide 製备试剂盒 (PSMA-11)）。这种前列腺癌影像剂旨在检测转移性前列腺癌，帮助医生识别转移性疾病并指导患者治疗决策。此药物适用于疑似转移且符合初始根治性治疗条件的患者，以及根据血清前列腺特异性抗原 (PSA) 水平升高而怀疑復发的患者。

目录

第一章执行摘要

第二章 市场特征

• 市场定义和范围
• 市场区隔
• 主要产品和服务概述
• 全球正子断层扫描（PET）放射性示踪剂市场：吸引力评分及分析
• 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

• 供应链与生态系概述
• 主要原料、资源和供应商清单
• 主要经销商和通路合作伙伴名单
• 主要最终用户列表

第四章 全球市场趋势与策略

• 关键技术和未来趋势
  • 生物技术、基因组学和精准医学
  • 工业4.0和智慧製造
  • 数位化、云端运算、巨量资料、网路安全
  • 永续性、气候技术和循环经济
  • 人工智慧（AI）和自主人工智慧
• 主要趋势
  • 标靶特异性放射性示踪剂的研发不断推进
  • PET影像在肿瘤诊断的应用日益广泛
  • 扩大除FDG以外的新同位素的使用范围
  • 扩大个人化核子医学的应用
  • 更重视生产短寿命放射性示踪剂

第五章 终端用户产业市场分析

• 医院
• 诊断中心
• 核子医学诊所
• 研究所
• 癌症治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

• 全球正子断层扫描（PET）放射性追踪剂市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 全球正子断层扫描（PET）放射性示踪剂市场规模、对比及成长率分析
• 全球正子断层扫描（PET）放射性示踪剂市场表现：规模与成长，2020-2025年
• 全球正子断层扫描（PET）放射性示踪剂市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

• 按放射性示踪剂的类型
• F-18（氟代脱氧葡萄糖-18）、Ga-68（纤维母细胞活化蛋白抑制剂）和其他类型的放射性追踪剂
• 透过使用
• 癌症、心臟病、消化器官系统、内分泌系统疾病、神经系统疾病及其他适应症
• 最终用户
• 医院、诊断中心和其他最终用户
• 按类型细分：F-18（氟代脱氧葡萄糖 18）
• F-18 FDG（氟代脱氧葡萄糖）、F-18 氟乙基酪胺酸（FET）、F-18 氟贝他吡（淀粉样蛋白 PET 影像）
• 按类型细分：Ga-68（纤维母细胞活化蛋白抑制剂）
• Ga-68 dotatate（神经内分泌肿瘤显像）、Ga-68 PSMA（前列腺特异性膜抗原显像）、Ga-68 FAPI（纤维母细胞活化蛋白抑制剂显像）
• 按类型细分：其他放射性示踪剂类型
• C-11（碳11）、N-13（氮13）、O-15（氧15）、Rb-82（铷82）、I-124（碘124）

第十章 区域与国家分析

• 全球正子断层扫描（PET）放射性追踪剂市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
• 全球正子断层扫描（PET）放射性示踪剂市场：按国家/地区、性能和预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

• 正子断层扫描（PET）放射性追踪剂市场：竞争格局与市场份额，2024年
• 正子断层扫描（PET）放射性示踪剂市场：公司估价矩阵
• 正子断层扫描（PET）放射性示踪剂市场：公司概况
  • Cardinal Health Inc.
  • GE Healthcare Technologies Inc.
  • Bracco Imaging SpA
  • Lantheus Holdings Inc.
  • Jubilant Pharma Limited

第37章：其他领先和创新企业

• SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions SA, ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications（Novartis）, Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

• 2030年正子断层扫描（PET）放射性追踪剂市场：提供新机会的国家
• 2030年正子断层扫描（PET）放射性追踪剂市场：提供新机会的细分市场
• 2030年正子断层扫描（PET）放射性追踪剂市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第41章附录

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

Tariffs are impacting the PET radiotracer market by increasing costs of imported radioisotopes, synthesis modules, cyclotron components, and quality control equipment. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported isotopes and production technologies, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing operational expenses and affecting tracer availability. However, they are also encouraging domestic isotope production, regional radiopharmacy expansion, and localized supply chain development.

The positron emission tomography (pet) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (pet) radiotracer market statistics, including positron emission tomography (pet) radiotracer industry global market size, regional shares, competitors with a positron emission tomography (pet) radiotracer market share, detailed positron emission tomography (pet) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (pet) radiotracer industry. This positron emission tomography (pet) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The positron emission tomography (pet) radiotracer market size has grown strongly in recent years. It will grow from $2.54 billion in 2025 to $2.78 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing cancer diagnosis rates, expansion of nuclear medicine facilities, established use of fdg-based imaging, availability of cyclotron infrastructure, growth of diagnostic imaging services.

The positron emission tomography (pet) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.95 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising investments in radiopharmaceutical R&D, expansion of theranostics applications, growing adoption of pet imaging in neurology and cardiology, increasing regulatory approvals for new tracers. Major trends in the forecast period include increasing development of target-specific radiotracers, rising adoption of pet imaging in oncology diagnostics, growing use of novel isotopes beyond fdg, expansion of personalized nuclear medicine applications, enhanced focus on short-half-life radiotracer production.

The rising prevalence of infectious diseases is expected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. The increasing occurrence of these diseases is attributed to factors such as climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which contribute to the spread of pathogens. PET radiotracers support the management of infectious diseases by enabling visualization of metabolic activity and inflammation, facilitating infection detection, evaluation of treatment response, and differentiation between infectious and non-infectious conditions, thereby improving patient outcomes. For example, in February 2024, a report published by the UK Health Security Agency, a UK-based government organization, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 cases in 2022. Consequently, the growing burden of infectious diseases is contributing to the expansion of the PET radiotracer market.

Companies active in the positron emission tomography (PET) radiotracer market are increasingly focusing on the development of advanced diagnostic solutions, including PET imaging agents, to improve cancer detection and patient outcomes. PET imaging agents are radioactive substances used to visualize and quantify biological processes within the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canada-based radiopharmaceutical company, launched Illuccix, also referred to as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada. This prostate cancer imaging agent is designed to detect metastatic prostate cancer and supports physicians in identifying metastatic disease and guiding patient management decisions. It is indicated for use in patients suspected of having metastasis who are candidates for initial definitive therapy, as well as in individuals with suspected recurrence based on elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a US-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed amount. This acquisition is intended to strengthen Lantheus Holdings' imaging pipeline, particularly in the area of Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a US-based company involved in the development of positron emission tomography (PET) radiotracers.

Major companies operating in the positron emission tomography (pet) radiotracer market are Cardinal Health Inc., GE Healthcare Technologies Inc., Bracco Imaging S.p.A., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications (Novartis), Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) radiotracer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (pet) radiotracer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
• 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
• 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
• 2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
• Companies Mentioned: Cardinal Health Inc.; GE Healthcare Technologies Inc.; Bracco Imaging S.p.A.; Lantheus Holdings Inc.; Jubilant Pharma Limited; SOFIE Biosciences; Yantai Dongcheng Pharmaceutical Group Co. Ltd.; Nordion Inc.; Isologic Innovative Radiopharmaceuticals; ABX Advanced Biochemical Compounds GmbH; IBA Radiopharma Solutions S.A.; ImaginAb Inc.; Radiomedix Inc.; Curium Pharma; Blue Earth Diagnostics Ltd.; Eckert & Ziegler Radiopharma GmbH; Advanced Accelerator Applications (Novartis); Telix Pharmaceuticals Limited; PETNET Solutions Inc.; Piramal Imaging
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Positron Emission Tomography (PET) Radiotracer Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Positron Emission Tomography (PET) Radiotracer Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Development Of Target-Specific Radiotracers
  • 4.2.2 Rising Adoption Of Pet Imaging In Oncology Diagnostics
  • 4.2.3 Growing Use Of Novel Isotopes Beyond Fdg
  • 4.2.4 Expansion Of Personalized Nuclear Medicine Applications
  • 4.2.5 Enhanced Focus On Short-Half-Life Radiotracer Production

5. Positron Emission Tomography (PET) Radiotracer Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Nuclear Medicine Clinics
• 5.4 Research Institutes
• 5.5 Cancer Treatment Centers

6. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Positron Emission Tomography (PET) Radiotracer Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Positron Emission Tomography (PET) Radiotracer Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Positron Emission Tomography (PET) Radiotracer Market Segmentation

• 9.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types
• 9.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications
• 9.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Centers, Other End-Users
• 9.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)
• 9.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 9.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

10. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

• 10.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

• 11.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Positron Emission Tomography (PET) Radiotracer Market

• 12.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Positron Emission Tomography (PET) Radiotracer Market

• 13.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Positron Emission Tomography (PET) Radiotracer Market

• 14.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Positron Emission Tomography (PET) Radiotracer Market

• 15.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Positron Emission Tomography (PET) Radiotracer Market

• 16.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Positron Emission Tomography (PET) Radiotracer Market

• 17.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Positron Emission Tomography (PET) Radiotracer Market

• 18.1. Taiwan Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Positron Emission Tomography (PET) Radiotracer Market

• 19.1. South East Asia Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Positron Emission Tomography (PET) Radiotracer Market

• 20.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Positron Emission Tomography (PET) Radiotracer Market

• 21.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Positron Emission Tomography (PET) Radiotracer Market

• 22.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Positron Emission Tomography (PET) Radiotracer Market

• 23.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Positron Emission Tomography (PET) Radiotracer Market

• 24.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Positron Emission Tomography (PET) Radiotracer Market

• 25.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

• 26.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Positron Emission Tomography (PET) Radiotracer Market

• 27.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Positron Emission Tomography (PET) Radiotracer Market

• 28.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Positron Emission Tomography (PET) Radiotracer Market

• 29.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Positron Emission Tomography (PET) Radiotracer Market

• 30.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Positron Emission Tomography (PET) Radiotracer Market

• 31.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Positron Emission Tomography (PET) Radiotracer Market

• 32.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Positron Emission Tomography (PET) Radiotracer Market

• 33.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Positron Emission Tomography (PET) Radiotracer Market

• 34.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Positron Emission Tomography (PET) Radiotracer Market Regulatory and Investment Landscape

36. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

• 36.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Positron Emission Tomography (PET) Radiotracer Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
  • 36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bracco Imaging S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Jubilant Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

37. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

• SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications (Novartis), Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

38. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

40. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

• 40.1 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer